Here, both the beclomethasone group and the CpGsd group could achieve a significant reduction of the IL‐4 concentration directly after treatment, analogous to the results of a study by Giguere, in which an inhalative fluticasone therapy also effected a decrease in the allergy‐mediating Th2 cytokine.54 The gene discussed is IL4; the disease is allergic disease.